$HIMS

Hims & Hers Health, Inc.

No enriched coverage for $HIMS in the last 7 days.

No SEC Form 4 filings for $HIMS in the last 30 days.

Med

HIMS vs. TDOC: Which Digital Health Stock Offers Better Upside Now?

This article compares Hims & Hers Health (HIMS) and Teladoc Health (TDOC), two digital health companies with distinct business models, to determine which offers better upside potential. HIMS focuses on consumer-centric telehealth and personalized treatments, while TDOC provides a comprehensive virtual care platform for employers and health systems. Despite TDOC's recent stock outperformance, the analysis suggests HIMS currently offers relatively better upside due to its growth trajectory and favorable risk-reward balance.

Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS

Kahn Swick & Foti, LLC (KSF) has launched an investigation into Hims & Hers Health, Inc. (HIMS) and its officers and directors following a securities class action lawsuit. This investigation stems from Novo Nordisk terminating its partnership with Hims & Hers, alleging the company failed to adhere to laws regarding mass sales of compounded drugs and disseminated deceptive marketing. A court has denied Hims & Hers' motion to dismiss the lawsuit, allowing the case to proceed.

10 Health Care Stocks Whale Activity In Today's Session

This article details "whale" options trading activity across ten health care stocks, including Edwards Lifesciences (NYSE:EW) and Hims & Hers Health (NYSE:HIMS). It provides specific examples of bullish, bearish, and neutral put and call option sweeps and trades, highlighting the strike prices, expiration dates, and total trade values. The piece aims to help traders identify potential opportunities by tracking significant institutional transactions.